For many investors, getting involved with pharmaceutical stocks involves finding inexpensive stocks, often penny stocks, in ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Stocks to Buy with Exponential Growth Heading into 2026.

Now, it’s worth noting Stock Advisor’s total average return is 1,033% — a market-crushing outperformance compared to 193 % ...

Sel Hardy of CFRA highlights Eli Lilly, Merck and Johnson & Johnson as top pharma picks amid strong pipelines and rising ...

While the S&P 500 is up 23.9% since April 2025, Royalty Pharma (currently trading at $36.80 per share) has lagged behind, ...

Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry that look like strong buys right now: Pfizer (NYSE: PFE) and Eli Lilly (NYSE ...

Novo Nordisk has submitted an unsolicited bid to buy obesity biotech Metsera out from under Pfizer, offering $6 billion ...

Novartis will pay Avidity shareholders $72 a share in cash, a premium of 46% to the company's Friday closing price.

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

Realty Income's business strategy is clear, straightforward, and it works. It is founded on long-term leases focused on what ...

Shuttle Pharmaceuticals shares fell after it signed a non-binding letter of intent to acquire Molecule.ai for $10 million in cash and stock. The stock was down 13% at $4.16 in the morning session.

Regarding stocks to buy on Monday, Sumeet Bagadia recommended three buy-or-sell stocks: Sun Pharma, KPIT Technologies, and ...